The Chest Pain Choice trial: a pilot randomized trial of a decision aid for patients with chest pain in the emergency department by Pierce, Meghan A et al.
TRIALS
Pierce et al. Trials 2010, 11:57
http://www.trialsjournal.com/content/11/1/57
Open AccessS T U D Y  P R O T O C O LStudy protocolThe Chest Pain Choice trial: a pilot randomized trial 
of a decision aid for patients with chest pain in the 
emergency department
Meghan A Pierce1,2, Erik P Hess*1,2, Jeffrey A Kline3, Nilay D Shah1,4, Maggie Breslin1,5, Megan E Branda1,6, 
Laurie J Pencille1, Brent R Asplin2, David M Nestler2, Annie T Sadosty2, Ian G Stiell7, Henry H Ting1,8 and 
Victor M Montori1,4,9
Abstract
Background: Chest pain is a common presenting complaint in the emergency department (ED). Despite the 
frequency with which clinicians evaluate patients with chest pain, accurately determining the risk of acute coronary 
syndrome (ACS) and sharing risk information with patients is challenging. The aims of this study are (1) to develop a 
decision aid (CHEST PAIN CHOICE) that communicates the short-term risk of ACS and (2) to evaluate the impact of the 
decision aid on patient participation in decision-making and resource use.
Methods/Design: This is a protocol for a parallel, 2-arm randomized trial to compare an intervention group receiving 
CHEST PAIN CHOICE to a control group receiving usual ED care. Adults presenting to the Saint Mary's Hospital ED in 
Rochester, MN USA with a primary complaint of chest pain who are being considered for admission for prolonged ED 
observation in a specialized unit and urgent cardiac stress testing will be eligible for enrollment. We will measure the 
effect of CHEST PAIN CHOICE on six outcomes: (1) patient knowledge regarding their short-term risk for ACS and the 
risks of radiation exposure; (2) quality of the decision making process; (3) patient and clinician acceptability and 
satisfaction with the decision aid; (4) the proportion of patients who decided to undergo observation unit admission 
and urgent cardiac stress testing; (5) economic costs and healthcare utilization; and (6) the rate of delayed or missed 
ACS. To capture these outcomes, we will administer patient and clinician surveys after each visit, obtain video 
recordings of the clinical encounters, and conduct 30-day phone follow-up.
Discussion: This pilot randomized trial will develop and evaluate a decision aid for use in ED chest pain patients at low 
risk for ACS and provide a preliminary estimate of its effect on patient participation in decision-making and resource 
use.
Trial registration: Clinical Trials.gov Identifier: NCT01077037
Background
Over 6 million adults present with chest pain in US emer-
gency departments (EDs) each year, making chest pain
the second most common presenting complaint [1].
Despite the frequency with which clinicians evaluate
patients with chest pain, reliably detecting patients with
acute coronary syndrome (ACS) remains a diagnostic
dilemma. Data from U.S. EDs suggest that 2.1% of
patients with acute myocardial infarction and 2.3% with
unstable angina are missed [2]. A missed diagnosis of
ACS may have substantial medical and legal implications
[3]. As a result, clinicians initiate formal diagnostic test-
ing for ACS at a very low risk threshold [4]. High sensitiv-
ity is ensured at the expense of specificity, resulting in
large numbers of very low risk patients being admitted to
ED observation units for urgent cardiac stress testing,
increased likelihood of false positive stress testing, exces-
sive exposure to ionizing radiation [5], and significant
cost to the healthcare system.
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lenge. When a patient presents to the ED with chest pain
and the initial evaluation for non-cardiac etiologies is
unrevealing, the focus of the evaluation shifts to estimat-
ing a patient's risk for ACS. Without the assistance of
decision support tools, clinicians are challenged to pre-
cisely quantify risk and often resort to terms such as
"low," "rare," or "uncommon" when communicating risk
to patients. One recent study reported that patients often
overestimate the level of potential harm when verbal
descriptors are used to communicate risk [6]. To increase
patient understanding of risk and optimize knowledge
transfer between physicians and patients, we will develop
and evaluate a decision aid that includes a precise esti-
mate of the short-term risk for ACS described using
prose phrases, numbers, and a pictograph to account for
patients' preferred mode of understanding numerical
information.
To date, the authors are unaware of any published
research investigating the specific role and impact of
shared decision making in patients at low risk for ACS.
We hypothesize that patients infrequently participate in
the decision to undergo prolonged observation and
urgent cardiac stress testing and that the use of a decision
aid to communicate both the short-term risk of ACS and
the risks of ionizing radiation exposure will increase
patient involvement in the decision making process, lead
to a preference-based decision, and safely decrease
resource use. To test our hypothesis, we will accomplish
the following specific aims: (1) develop and refine CHEST
PAIN CHOICE, a decision aid to communicate the short-
term risk for an ACS and the available management
options and (2) test the effect of CHEST PAIN CHOICE,
in a randomized clinical trial, on patient knowledge, the
quality of the decision making process, patient safety, and
resource use.
Methods
Design
To evaluate the decision aid, we will conduct a patient-
level single center pilot randomized trial. The Mayo
Clinic Institutional Review Board has approved all study
procedures.
Setting
Patients and emergency physicians will be recruited from
the Saint Marys Hospital ED at the Mayo Clinic, a tertiary
care academic ED with an annual census of 73,000 patient
visits. The trial will be conducted in the flow of routine
patient care. This approach will enable us to test how the
decision aid performs in the real-world setting.
Participants
Inclusion criteria
Eligible providers will include clinicians (attending physi-
cians, supervised residents, nurse practitioners and phy-
sician assistants) caring for patients with chest pain.
Eligible patients will include adults (>17 years of age) pre-
senting to the ED with a primary complaint of non-trau-
matic chest pain who are being considered for admission
to the ED observation unit for urgent cardiac stress test-
ing.
Exclusion criteria
The trial will exclude patients with an initial cardiac tro-
ponin T value above the 99th percentile reference limit
(Roche Diagnostics [Basel, Switzerland]; 99th percentile
<0.01 ng/mL; lower limit of detection 0.01 ng/mL; 10%
coefficient of variation 0.035 ng/mL) [7], known coronary
artery disease (at least one 50% stenosis on cardiac cathe-
terization, electrocardiographic changes [old or not
known to be old] indicative of ischemia such as ST-T
changes or left bundle branch block, perfusion defects or
wall motion abnormalities on exercise, pharmacologic or
rest imaging studies, or previous documentation of acute
myocardial infarction) [8], cocaine use within 72 hours by
the clinician's initial history, and pregnancy. Patients who
cannot read English or have, in their clinician's best judg-
ment, major communication barriers such as visual or
hearing impairment or dementia that would compromise
their ability to give written informed consent (or use the
decision aid) will be excluded.
Participant recruitment
We have previously developed and validated an electronic
notification system that is highly sensitive and specific for
identifying potentially eligible participants presenting to
the ED with chest pain as a primary complaint (sensitivity
97.8%, 95% CI 96.1-98.8; specificity 98.3%, 95% CI 98.0-
98.5; positive predictive value 68.8%, 95% CI 65.4-72.9;
negative predictive value 99.9%, 95% CI 99.8-100.0) [9].
Shortly after arrival to the ED, a study coordinator will
receive electronic notification of potentially eligible par-
ticipants in real time by both pager and email. In collabo-
ration with the treating physician, the coordinator will
confirm eligibility for the trial. The coordinator will then
inform patients about the trial and obtain written
informed consent. Patients will be consecutively enrolled
6-7 days per week when a study coordinator is available
for enrollment.
Interventions
Decision aid
The CHEST PAIN CHOICE decision aid prototype has
been developed through an iterative process involving
collaboration between designers and researchers, field-
testing by patients and clinicians, and revision of the
decision aid in response to the feedback provided. We
have employed this methodology to develop the prior
decision aids STATIN CHOICE [10] (assists providers in
discussing the benefits and side effects of statins among
patients with diabetes) and OSTEOPOROSIS CHOICE
[11] (assists with the decision to take bisphosphonates
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fracture) [12,13].
Selection of a risk calculator for the decision aid
We recently conducted a systematic review to identify
clinical prediction tools of sufficient diagnostic accuracy
and methodological quality to consider for incorporation
in clinical practice [14]. Of the clinical prediction tools
that have been developed for ED patients with potential
ACS, only 3 have been prospectively validated and thus
could be considered for use in clinical practice - the
Global Registry of Acute Coronary Events (GRACE)
score, the Thrombolysis in Myocardial Infarction (TIMI)
risk score, and the computerized quantitative pretest
probability calculator. The GRACE risk score has been
validated in only one ED study, and in this study data
were not available to calculate a complete risk score in
26% of patients [15]. Although the TIMI risk score has
been validated in over 17,000 ED patients in 5 different
countries and can provide a reliable estimate of the risk
for a cardiac event within 30 days of the ED visit, it has
not undergone impact analysis [16]. The pretest probabil-
ity calculator developed by Kline et al., unlike the TIMI
risk score, has undergone impact analysis, demonstrating
its true impact on patient care [17]. The pretest probabil-
ity calculator was derived from data from 14,796 patients
enrolled in the multicenter internet tracking registry of
ACS database and prospectively validated in 8,120 ED
patients with potential ACS [18]. The pretest probability
calculator has since been prospectively validated in a
multicenter study of 1,114 patients from 3 different aca-
demic EDs [19] and undergone impact analysis in a prac-
tical randomized trial [17]. For these reasons, we chose to
use this calculator (Figure 1) to inform our decision aid
CHEST PAIN CHOICE.
Randomization
We will use a dynamic allocation procedure described by
Pocock and Simon [20] to randomly allocate patients via
a computer-generated allocation sequence in a 1:1 con-
cealed fashion to one of two arms: (1) a CHEST PAIN
CHOICE arm in which the provider and patient will be
provided a printout of the decision aid or (2) a usual care
arm in which the provider will discuss the management
options in their usual fashion without the decision aid or
pretest probability calculator.
Given the limited amount of information that is avail-
able during the initial ED encounter and the known asso-
ciation of age and sex with cardiovascular risk, we will
dynamically stratify by age and sex in the allocation pro-
cess to ensure that the treatment arms are balanced in
regard to these factors. To enroll patients in the trial, the
study coordinator will complete the following:
• Assess patient eligibility in collaboration with the
treating physician and obtain written informed con-
sent from both parties.
• Access a secure website, input key patient character-
istics, and obtain from the website interface the arm
to which the patient is allocated.
After randomization, outcome assessors and data ana-
lysts will remain blind to allocation. In the event that a
patient is suspected of being incorrectly enrolled (i.e., it is
discovered after randomization that the patient is ineligi-
ble for the trial), the study coordinator will present the
case to the principle investigator (E.P.H.) for review. The
principle investigator, blinded to both allocation arm and
patient outcome, will then consider post-randomization
exclusion according to published recommendations [21].
The main disadvantage of randomization at the patient
level is reducing the risk of contamination in the control
group. Providers may be aware of the hypothesis that use
of CHEST PAIN CHOICE will increase the quality of the
decision-making process, increase patient knowledge,
and decrease resource use. However, we anticipate that
clinicians will revert to their usual pattern of practice
without the calculator -- since access to it is password-
protected -- and be reluctant to dismiss patients from the
ED. We will also monitor for evidence of contamination
by reviewing the video recordings of clinician-patient
encounters in the control group.
Intervention arm
For patients randomized to the intervention arm, the
study coordinator will review the contents of the decision
aid in real time with the clinician immediately before the
patient encounter. This approach to delivering the deci-
sion aid (with just-in-time training by the study coordina-
tor prior to use) has been effectively used in our prior
decision aid studies [22]. We have observed a trend
towards superior results when the decision aid is deliv-
ered by the clinician compared to researchers delivering
the tool prior to the clinical encounter [23].
Usual care
For patients randomized to the usual care arm, the clini-
cians will discuss the results of the diagnostic investiga-
tions and management options with the patient in that
clinician's usual fashion. We will videotape the patient-
clinician discussion for future review. No research-
related interventions will be administered.
Outcome measures
Decision-based outcome measures take into account
both the Ottawa Framework for Shared Decision Making
[24] and self determination theory [25]. To assess the effi-
cacy of the decision aid, we will measure the effect of
CHEST PAIN CHOICE on the following outcomes: (1)
patient knowledge regarding their short-term risk for
ACS and the risks of radiation exposure; (2) quality of the
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(3) patient and clinician acceptability and satisfaction
with the decision aid. We will also assess (4) the propor-
tion of patients who decide to undergo observation unit
admission and urgent cardiac stress testing; (5) economic
costs and healthcare utilization; and (6) the rate of
delayed or missed ACS (primary safety endpoint). The
diagnosis of ACS will be considered delayed or missed if
the patient was dismissed from the ED without observa-
tion unit admission and urgent stress testing and they
meet the definition of ACS within 30 days of the ED visit.
ACS will be defined as acute myocardial infarction [26],
ventricular arrhythmia, cardiogenic shock, bradycardia
requiring therapeutic intervention, or death attributed to
a cardiac or unknown cause. Two investigators, blinded
to allocation, will assess outcomes in all enrolled patients.
A third investigator will resolve discordances.
A study coordinator will review the electronic medical
record and conduct telephone follow-up for all enrolled
patients starting at 30 days. The coordinator will verify
the patient's telephone number at the time of enrollment
to maximize the fidelity of follow-up. For those who are
unable to be contacted by phone, we will use the
resources of the Rochester Epidemiology Project [27] to
determine outcomes for all Olmsted County residents
and the social security death index [28] for patients who
live outside of Olmsted County. We will note the success
with enrollment and document the rate of 30-day follow-
up.
Data collection
We will survey patients and clinicians after each visit and
videotape the decision aid discussion between the clini-
cian and patient in both the intervention and control
groups to capture outcomes. The patient surveys (see
Additional files 1 and 2 for complete list of survey ques-
tions) will include:
• Items about level of education and income level for
descriptive purposes
• Questions regarding the patient's comfort level in
understanding different types of numerical informa-
tion (e.g., fractions, percentages, graphs)
• 7 items to assess patient knowledge, 2 of which
address the risks of radiation exposure, 2 that address
the available management options, 2 about the poten-
tial implications of cardiac stress test results (not
informed by content on the decision aid), and one
question about the patient's personalized risk for ACS
within 45 days of the ED visit. These items were fash-
ioned after similar questions, which have demon-
Figure 1 Chest Pain Choice Decision Aid.
2 Further Tests  A STRESS TEST EVALUATION may more 
precisely determine if your heart is functioning 
correctly by viewing blood flow to your heart  
while at rest and under stress. 
Examining your risk will help you to determine 
whether you would like to have a stress test  
now or would like assistance in making a clinic 
appointment.1 
3 Your Personal Risk Evaluation Your risk of having a heart attack or of having a 
pre-heart attack diagnosis within the next 45 days can  
be determined by comparing you to people with similar 
factors2 who also came to the Emergency Department 
with chest pain.
4 Would You Like to Have a Stress Test Now or Make an Appointment?
❏    I would like to be admitted to the observation 
unit to have an urgent cardiac stress test.  
I realize that this could add to the cost of my 
evaluation and lengthen my emergency stay.
❏    I would like to be seen by a Mayo Clinic heart 
doctor within 24-48 hours and would like  
assistance in scheduling this appointment.
❏    I would like to schedule an appointment on my 
own to consult with my primary care physician.
❏    I would like my emergency department doctor  
to make this decision for me.
What’s Next? 
1 Your Chest Pain Diagnosis Our initial evaluation has NOT shown any 
evidence of a heart attack. This conclusion is 
based on a blood test (to look for troponins 
— enzymes that are released when the heart 
muscle is damaged) and an electrocardiogram  
(to check that your heart is getting enough 
oxygen and blood). Over the next five hours,  
two additional blood tests (troponins) will be 
taken to definitively rule out a heart attack. 
However, even if these tests do confirm our 
diagnosis, your chest pain may indicate possible 
warning signs of a FUTURE heart attack. 
Prepared for:
5 
had a heart attack  
or a pre-heart 
attack diagnosis 
within 45 days  
of their emergency 
department visit,
95
did not.
 
Of every 
100 
people with  
factors like yours 
who came to  
the emergency  
department  
with chest pain...
1Stress test options include nuclear stress testing, 
ultrasound stress testing, and exercise ECG 
(electrocardiogram) stress testing. Nuclear stress 
testing includes exposure to radiation which has been 
shown to be related to increased cancer risk over a 
lifetime. Your doctor can help you explore which option 
may be best for you.
©2010 Mayo Foundation for Medical Education and Research. All rights reserved.
2 t Age
t Gender
t Race
t  If chest pain is made worse when manual pressure is applied 
to the chest area
t  If there is a history of coronary artery disease
t If the chest pain causes perspiration
t  Findings on electrocardiograms (electronic tracings of the heart)
t Initial cardiac troponin T result
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intervention in previous decision aid trials [29,30].
• 5 items using a 7-point Likert-type scale to assess
the patient's perceptions about the amount, clarity
and helpfulness of the information, their desire to
receive information about other diagnostic options in
the same way this information was delivered, and
whether they would recommend the way they
received information from their clinician during this
encounter to other patients. We have used the same
items in our previous trials [11,30].
• 10 items from the Trust in Physician scale [31]
• 17 items from the Decisional Conflict Scale [32],
which assesses the extent to which the decision was
informed, consistent with values, free of pressure, and
effective
• Additional questions that inquire about the decision
made by the patient during the visit and patient satis-
faction with the degree of participation in the deci-
sion making process.
The treating clinician will be asked to complete a sur-
vey after each study visit (see Additional file 3). The sur-
vey includes questions regarding which decision the
patient made, the clinician's perception of who made the
decision, the clinician's confidence in the patient's under-
standing of the information, and questions regarding the
acceptability of the decision aid.
The discussion between the patient and clinician
regarding the risks and benefits of further evaluation (i.e.
observation unit admission with stress testing versus
urgent follow-up with cardiology or follow-up with the
patient's primary physician) and explanation of the
CHEST PAIN CHOICE decision aid by the treating clini-
cian will be video recorded to determine the degree of
patient participation in the decision making process. We
will use the OPTION scale [33] to evaluate the quality of
the decision making on the video recordings. The scale
enables an observer to quantify the extent to which clini-
cians involve patients in the decision making process. We
have used the OPTION scale with adequate reliability in
previous studies [22,34]. Video recordings will also pro-
vide information regarding the duration of the encounter
(using video time stamps), fidelity of use of the tool, and
difficulties encountered while using the decision aid.
We will conduct an economic evaluation of the trial
using the Olmsted County Healthcare Expenditure and
Utilization Database (OCHEUD). We will limit the analy-
sis to subjects residing in Olmsted County, Minnesota
since we have complete data on medical care utilization
for this population. OCHEUD is a claims-based database
that contains information on medical resource utiliza-
tion, associated charges, and estimated economic costs
for patients receiving care at either the Olmsted Medical
Center or the Mayo Clinic and their associated inpatient
facilities. Although the services provided represent the
clinical practice patterns of Mayo Clinic and Olmsted
Medical Center providers, the value of each unit of ser-
vice has been adjusted to national norms by use of widely
accepted valuation techniques. OCHEUD provides an
estimated economic cost for each line item in the billing
record and allows the aggregation of costs into categories
deemed relevant to a particular study. The database
serves as a major source of financial information on all
patients (i.e., irrespective of payer) and includes line-item
detail on date, type, frequency, and billed charge for every
good or service provided. We will use data from the
OCHEUD database to compare costs and utilization
between the intervention and control groups. We will
further compare the types of services that were used in
each of the groups.
Statistical considerations
We have sufficient funding to enroll and randomize 200
patients. While this number is insufficient to definitively
assess the efficacy of the decision aid and its effect on the
proportion of patients who decide to undergo observa-
tion unit admission and urgent cardiac stress testing, it is
sufficient to determine the following:
• for knowledge gains, assuming the patients in the
control group will, on average, answer 4 of the 7 ques-
tions correctly, we will have 90% power to detect a
>25.7% increase in mean knowledge (to a mean of 5.8
questions answered correctly) in the intervention
group, assuming equal variances between the two
arms and alpha = 0.05;
• for the proportion of patients who decide to
undergo observation unit admission and stress test-
ing, assuming that at least 90% of patients in the con-
trol group will be admitted to the ED observation unit
(null hypothesis), we will have 95% power to detect a
20% decrease in the proportion of patients who
decide to be admitted to the ED observation unit for
stress testing (from 90% to 70%; alternative hypothe-
sis) in the decision aid treatment group, with a two-
sided test at a 5% significance level.
The feasible sample size is also adequate to provide a
plausible effect size to plan a definitive multicenter ran-
domized trial.
We will report baseline characteristics potentially asso-
ciated with study outcomes (age, gender, education level,
numeracy, pretest probability for acute coronary syn-
drome, smoking history, proportion of patients with
hypercholesterolemia, and proportion with a family his-
tory of premature coronary artery disease) separately for
the intervention and control group. Each factor will be
compared using either the Chi-square or Fisher's exact
test for categorical variables, depending on which is
appropriate for that factor. The continuous factors will be
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appropriate. Any imbalance found within a risk factor will
be explored as a possible factor to adjust for when the
outcome measures are being analyzed. Any p-value < 0.10
will be considered a possible imbalance.
Study data will be collected and managed using RED-
Cap electronic data capture tools hosted at the Mayo
Clinic [35]. REDCap (Research Electronic Data Capture)
is a secure, web-based application designed to support
data capture for research studies, providing: 1) an intui-
tive interface for validated data entry; 2) audit trails for
tracking data manipulation and export procedures; 3)
automated export procedures for seamless data down-
loads to common statistical packages; and 4) procedures
for importing data from external sources.
Continuous variables will be reported as mean (± S.D.)
or medians with interquartile ranges as appropriate for
the distribution of the data. Categorical data will be pre-
sented as percent frequency of occurrence. Variables will
be compared using relative (relative risk) or absolute
(mean differences) measures of association and their 95%
confidence intervals. To test hypotheses of association,
we will use Wilcoxon rank-sum tests to compare medi-
ans, and Chi-square or Fisher's exact tests to compare fre-
quencies. All analyses will be based on two-sided tests at
a significance level of 0.05. We will follow the intention to
treat principle in our analysis, making every effort to
avoid missing data and analyzing patients according to
the arm to which they were randomized. All analyses will
be conducted using SAS software (SAS institute, Inc,
Carey, NC, USA) version 9.1 TS level 1M3.
Discussion
We have described the design of a clinical trial to deter-
mine the effectiveness of a decision aid on patient partici-
pation in decision-making and resource use in ED chest
pain patients at low risk for ACS. While this is a feasibility
trial for a new decision aid, it will provide an estimate of
the effect of the decision aid that can be used to inform
the design of a larger multicenter trial.
An important reason to conduct feasibility trials of
decision aids designed for use in the clinical setting is that
the tools have potential to impact the nature and content
of the patient-physician discussion and the duration of
the clinical evaluation. Patients who present to the ED
with chest pain may be in a vulnerable emotional state
such that they prefer decisions be made on their behalf
rather than actively participate in their medical care. The
ED is also the safety net for patients of all levels of educa-
tion and for those without medical insurance, and we
anticipate that there may be knowledge transfer chal-
lenges that are unique to this practice setting. When cli-
nicians with different practice patterns and level of
experience use the decision aid, they may not find it
appropriate to use for some patients or may not use the
decision aid appropriately. Therefore, video recording the
patient-clinician encounter may provide insight into
these potential challenges, the effectiveness of the deci-
sion aid, and the nature of the patient-physician interac-
tion in a busy ED environment. The results of this study
may guide process changes in trial design, changes in
inclusion and exclusion criteria, refinement of the deci-
sion aid itself, and data to estimate a sample size for
design of a larger efficacy study.
In conclusion, there is an urgent need to develop and
evaluate a shared decision making approach to patients
presenting with chest pain to the ED. Chest pain is a com-
mon complaint in EDs that challenges emergency clini-
cians to provide an accurate, safe, and efficient diagnosis.
Clinicians seem to have a very low risk tolerance and ini-
tiate diagnostic testing in patients with a very low pre-test
probability of disease. Overtesting for ACS increases the
likelihood of false positive stress testing, exposes patients
unnecessarily to ionizing radiation, worsens ED over-
crowding, and increases the cost of care. Developing and
testing a decision aid that transparently communicates
the short-term risk for ACS to both clinicians and
patients, the potential risks of radiation exposure, and the
available management options is a novel approach to
solving a common clinical problem in a patient-centered
fashion. Our approach differs from prior risk stratifica-
tion studies of ED patients with potential ACS in that it
seeks to enhance patient involvement in the decision
making process rather than relying solely on diagnostic
accuracy (i.e., ruling out ACS with 100% sensitivity). We
hypothesize that use of CHEST PAIN CHOICE will
increase patient knowledge and involvement in the deci-
sion making process, decrease physician and patient anx-
iety, and safely decrease resource use in ED patients with
chest pain. We will also continue to develop the expertise
of our group in the conduct of decision aid trials in com-
plex real-world settings.
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